Artrya Limited (ASX:AYA)

Australia flag Australia · Delayed Price · Currency is AUD
3.100
+0.010 (0.32%)
Mar 3, 2026, 4:10 PM AEST
278.05%
Market Cap 490.06M
Revenue (ttm) 29.00K
Net Income (ttm) -19.71M
Shares Out 158.08M
EPS (ttm) -0.17
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 478,529
Average Volume 427,399
Open 3.100
Previous Close 3.090
Day's Range 2.910 - 3.105
52-Week Range 0.560 - 5.240
Beta 0.55
RSI 39.03
Earnings Date May 26, 2026

About Artrya

Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia. [Read more]

Sector Healthcare
Founded 2018
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol AYA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.